Treffers E, Duijndam S, Schiffer A S, Scherders M J, Habibović M, Denollet J
Department of Medical Psychology, Catharina Ziekenhuis Eindhoven, Eindhoven, the Netherlands.
Tilburg University, Department of Medical and Clinical Psychology, and Center of Research on Psychology and Somatic disorders (CoRPS), Tilburg, the Netherlands.
Gen Hosp Psychiatry. 2021 Nov-Dec;73:1-8. doi: 10.1016/j.genhosppsych.2021.08.011. Epub 2021 Aug 28.
Social inhibition may promote symptoms of depression and anxiety in adults from an outpatient hospital population. The current work builds on a previously corroborated construct of social inhibition and examines the psychometric properties of this assessment tool and its predictive validity in the adult outpatient hospital population.
A total of 350 adult outpatients receiving treatment at the department of Medical Psychology or Psychiatry completed measures of social inhibition and symptoms of anxiety (7-item Generalized Anxiety Disorder scale) and depression (9-item Patient Health Questionnaire). Factor analyses, reliability estimates, and regression analyses were used to replicate the robustness of the model of social inhibition, and the 15-item Social Inhibition Questionnaire (SIQ15).
In the current sample (N = 350; M = 45 years; 67.4% women), factor analyses confirmed the previously suggested three-factor model of social inhibition as measured by the SIQ15. The subscales of behavioral inhibition, interpersonal sensitivity and social withdrawal proved to be internally consistent (Cronbach's α between 0.87/0.95) and stable over time (test-retest reliability between r = 0.76/0.83). At baseline, interpersonal sensitivity and social withdrawal were associated with anxiety and depressive symptoms. At three months follow-up, only interpersonal sensitivity was related to depressive symptoms.
Social inhibition is associated with anxiety and depression at baseline and can be reliably assessed with the SIQ15 in an outpatient hospital population. The association of interpersonal sensitivity with depressive symptoms at three-month follow-up suggests an important aim for future research on the development of preventive methods for affective symptoms in socially inhibited outpatients.
社交抑制可能会加重门诊成年患者的抑郁和焦虑症状。本研究基于先前得到证实的社交抑制结构,检验该评估工具的心理测量特性及其在成年门诊患者群体中的预测效度。
共有350名在医学心理学或精神病学科室接受治疗的成年门诊患者完成了社交抑制测量以及焦虑症状(7项广泛性焦虑障碍量表)和抑郁症状(9项患者健康问卷)的测量。采用因子分析、信度估计和回归分析来验证社交抑制模型及15项社交抑制问卷(SIQ15)的稳健性。
在当前样本(N = 350;M = 45岁;67.4%为女性)中,因子分析证实了先前提出的由SIQ15测量的社交抑制三因素模型。行为抑制、人际敏感性和社交退缩分量表在内部具有一致性(Cronbach's α在0.87/0.95之间)且随时间稳定(重测信度在r = 0.76/0.83之间)。在基线时,人际敏感性和社交退缩与焦虑和抑郁症状相关。在三个月随访时,只有人际敏感性与抑郁症状相关。
社交抑制在基线时与焦虑和抑郁相关,并且在门诊患者群体中可以通过SIQ15进行可靠评估。三个月随访时人际敏感性与抑郁症状的关联为未来研究社交抑制门诊患者情感症状预防方法的发展提供了一个重要目标。